FDA Inspection 1254312 — Itrace Pharmaceutical Solutions Private Limited

Itrace Pharmaceutical Solutions Private Limited — FEI 3018238790

The FDA completed an inspection of Itrace Pharmaceutical Solutions Private Limited on Nov 15, 2024 in Thane. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 15, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Thane (India)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.